GLP-1RAs for IBD
US$ 28.35
glp 1 agonists adverse effects of GLP-1 class drugs. Gastrointestinal issues are GLP-1 Agonists For Obesity In
Description
Treating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists
The findings identified Comp68, Comp70, and Comp71 as promising DPP4is with high selectivity scores and favorable MD total energies
2023;46(Supplement 1):S140S157
Semaglutide Lowers Body Weight in Rodents via Distributed Neural Pathways
Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer
However, given the associated risks of cardiovascular disease and various cancers, the benefits of these medications, such as better glycemic control, weight loss and improvement in cardiometabolic risk factors as well as other obesity complications, appear to outweigh the risks for most adults with obesity [143, 153]
